Amivantamab monotherapy in relapsed/refractory metastatic colorectal cancer: OrigAMI-1, an open-label, phase 1b/2 study. This is an ASCO Meeting Abstract from the 2024 ASCO Gastrointestinal Cancers ...
A phase 2 trial to evaluate the efficacy and safety of WZTL-002, a third-generation anti-CD19 CAR T-cell therapy, in patients with relapsed or refractory large B-cell lymphoma (ENABLE-2). This is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results